Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Yazdan YAZDANPANAH"'
Autor:
Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, Maude Bouscambert-Duchamp, Drifa Belhadi, Alpha Diallo, Christelle Delmas, Juliette Saillard, Aline Dechanet, Noémie Mercier, Axelle Dupont, Toni Alfaiate, François-Xavier Lescure, François Raffi, François Goehringer, Antoine Kimmoun, Stéphane Jaureguiberry, Jean Reignier, Saad Nseir, François Danion, Raphael Clere-Jehl, Kévin Bouiller, Jean-Christophe Navellou, Violaine Tolsma, André Cabie, Clément Dubost, Johan Courjon, Sylvie Leroy, Joy Mootien, Rostane Gaci, Bruno Mourvillier, Emmanuel Faure, Valérie Pourcher, Sébastien Gallien, Odile Launay, Karine Lacombe, Jean-Philippe Lanoix, Alain Makinson, Guillaume Martin-Blondel, Lila Bouadma, Elisabeth Botelho-Nevers, Amandine Gagneux-Brunon, Olivier Epaulard, Lionel Piroth, Florent Wallet, Jean-Christophe Richard, Jean Reuter, Thérèse Staub, Bruno Lina, Marion Noret, Claire Andrejak, Minh Patrick Lê, Gilles Peytavin, Maya Hites, Dominique Costagliola, Yazdan Yazdanpanah, Charles Burdet, France Mentre
ObjectivesWe evaluated the clinical, virological and safety outcomes of lopinavir/ritonavir, lopinavir/ritonavir-interferon (IFN)-β-1a, hydroxychloroquine or remdesivir in comparison to standard of care (control) in COVID-19 inpatients requiring oxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ad233f5cf3786f4896204b650e0e53e
https://doi.org/10.1101/2022.02.16.22271064
https://doi.org/10.1101/2022.02.16.22271064
Autor:
Maude Bouscambert-Duchamp, Drifa Belhadi, Guillaume Lingas, Yazdan Yazdanpanah, Maya Hites, Florent Wallet, Thérèse Staub, José Artur Paiva, Richard Greil, Julien Poissy, Charles Burdet, Amandine Gagneux-Brunon, Alexandre Gaymard, Nadège Néant, Jeremie Guedj, Dominique Costagliola, Gilles Peytavin, Florence Ader, Nathan Peiffer-Smadja
Despite several clinical studies, the antiviral efficacy of remdesivir in COVID-19 hospitalized patients remains controversial. We analyzed nasopharyngeal normalized viral loads collected in the 29 days following randomization from 665 hospitalized p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b5d9b2dece66e82830d26bc96ffb813
https://doi.org/10.1101/2021.10.19.21265209
https://doi.org/10.1101/2021.10.19.21265209
Autor:
Vanessa Granger, Philippe Montravers, Paul-Henri Wicky, Renato C. Monteiro, Yazdan Yazdanpanah, Sylvie Chollet-Martin, Jean-François Timsit, François-Xavier Lescure, Dounia Khelifi-Touhami, Marine Peyneau, Alexy Tran-Dihn, Margarita Hurtado-Nedelec, Luc de Chaisemartin
COVID-19 can cause acute respiratory distress syndrome (ARDS), leading to death in a significant number of individuals. Evidence of a strong role of the innate immune system is accumulating, but the precise cells and mechanism involved remain unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::539381fa866771494005cccc541d3353
https://doi.org/10.1101/2021.03.29.21254560
https://doi.org/10.1101/2021.03.29.21254560
Autor:
Giuseppe Pantaleo, Delphine Bachelet, Mathieu Surenaud, Boris P. Hejblum, Fabiola Blengio, Rodolphe Thiébaut, Minerva Cervantes, Matthieu Perreau, Christine Lacabaratz, Yves Levy, Aurélie Wiedemann, Pascaline Tisserand, Mélany Durand, Cédric Laouénan, Yazdan Yazdanpanah, Lila Bouadma, Benjamin Hivert, Jean-François Timsit, Marie Dechenaud, Hakim Hocini, Cécile Lefebvre, Marine Gautier, Emile Foucat
COVID-19 SARS-CoV-2 infection exhibits wide inter-individual clinical variability, from silent infection to severe disease and death. The identification of high-risk patients is a continuing challenge in routine care. We aimed to identify factors tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc26c72621036432e2130dedb3abc748
https://doi.org/10.1101/2020.12.12.20246934
https://doi.org/10.1101/2020.12.12.20246934
Autor:
Yazdan Yazdanpanah, Simon Cauchemez, Vittoria Colizza, Cécile Tran Kiem, Bruno Lina, Paolo Bosetti, Arnaud Fontanet
We used a mathematical model to evaluate the impact of mass testing in the control of SARS-CoV-2. Under optimistic assumptions, we find that one round of mass testing may reduce daily infections by up to 20-30%. As a consequence, very frequent testin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1756c502332ef391919b94c48689cefe
https://doi.org/10.1101/2020.12.08.20246009
https://doi.org/10.1101/2020.12.08.20246009
Autor:
Xavier Duval, Charlotte Charpentier, Yazdan Yazdanpanah, Benoit Visseaux, Lila Bouadma, Mélanie Bertine, Nabil Benmalek, Cédric Laouénan, Sarah Tubiana, Christophe Choquet, Nadhira Houhou-Fidouh, Houria Ichou, Florence Damond, Jade Ghosn, Diane Descamps, Quentin Le Hingrat, Jean-François Timsit
BackgroundMolecular assays on nasopharyngeal swabs remain the cornerstone of COVID-19 diagnostic. Despite massive worldwide efforts, the high technicalities of nasopharyngeal sampling and molecular assays, as well as scarce resources of reagents, lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6c68f3d8ea9c24a67ac074cf833c98c
https://doi.org/10.1101/2020.09.14.20191759
https://doi.org/10.1101/2020.09.14.20191759
Autor:
Yazdan Yazdanpanah, Nathan Peiffer-Smadja, François-Xavier Lescure, Erwan Sallard, Jeremie Guedj, Charles Burdet
IntroductionEfficient therapeutic strategies are needed to counter the COVID-19 pandemic, caused by the SARSCoV-2 virus. In a context where specific vaccines are not yet available, the containment of the pandemic would be facilitated with efficient p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e73d0c91efda397f7bb4c36670c413c3
https://doi.org/10.1101/2020.05.30.20117937
https://doi.org/10.1101/2020.05.30.20117937
Autor:
Paraskevi C. Fragkou, Drifa Belhadi, Nathan Peiffer-Smadja, Charalampos D. Moschopoulos, François-Xavier Lescure, Hannah Janocha, Emmanouil Karofylakis, Yazdan Yazdanpanah, France Mentré, Chrysanthi Skevaki, Cédric Laouénan, Sotirios Tsiodras
BackgroundAs COVID-19 cases continue to rise globally within an unprecedented short period of time, solid evidence from large randomised controlled trials is still lacking. Currently, numerous trials testing potential treatment and preventative optio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::277069e774611c53527b6f3f6edb5322
https://doi.org/10.1101/2020.04.27.20080226
https://doi.org/10.1101/2020.04.27.20080226
Autor:
Lucie Le Fevre, Diane Descamps, Sylvie van der Werf, Nicolas Escriou, Delphine Planas, Olivier Schwartz, Flora Donati, Cyril Planchais, Rémy Robinot, Isabelle Staropoli, Bernadette Crescenzo, Bruno Hoen, Mireille Nowakowski, Marion Gransagne, Mélanie Albert, Jérémy Dufloo, Marc Eloit, Stéphane Petres, Camille Besombes, Ludivine Grzelak, Yazdan Yazdanpanah, Hugo Mouquet, Sarah Temmam, Arnaud Fontanet, Pierre Charneau, Marija Backovic, Vincent Enouf, Pascal Morel, Françoise Porrot, Quentin Le Hingrat, Audrey Lemaitre, Timothée Bruel, Philippe Souque, Maxime Chazal, Guillaume Mellon, Laura Tondeur, Anabelle Pourbaix, Simon Rolland, Félix A. Rey, Christèle Huon, Julian Buchrieser, Sylvie Behillil, Marie-Noëlle Ungeheuer, François Anna, Maaran Michael Rajah, Lila Bouadma, Florence Guivel, Jacques Bellalou, Marie-Aude Creach, Caroline Demeret, Kuang-Yu Chen
It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic cases of SARS-CoV-2 infection and their antibody response profile. Here, we performed a pilot study to assess the levels of anti-SARS-CoV-2 antibodies in sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7169199373c1a8660e7c80ea5dce6bc
https://doi.org/10.1101/2020.04.21.20068858
https://doi.org/10.1101/2020.04.21.20068858
Autor:
Drifa Belhadi, Nathan Peiffer-Smadja, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentré, Cédric Laouénan
BackgroundAlthough a number of antiviral agents have been evaluated for coronaviruses there are no approved drugs available. To provide an overview of the landscape of therapeutic research for COVID-19, we conducted a review of registered clinical tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff1c66ee2fc1e366ef06f9968547fe7a